1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Clinical AI Model Governance Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Clinical AI Model Governance Market, by Component
8.1.1. Software Platforms
8.1.1.1. Market Revenue and Forecast
8.1.2. Services (Consulting, Implementation, Monitoring & Support)
8.1.2.1. Market Revenue and Forecast
9.1. Clinical AI Model Governance Market, by Deployment Mode
9.1.1. Cloud-Based
9.1.1.1. Market Revenue and Forecast
9.1.2. On-Premises
9.1.2.1. Market Revenue and Forecast
9.1.3. Hybrid
9.1.3.1. Market Revenue and Forecast
10.1. Clinical AI Model Governance Market, by Application
10.1.1. Model Validation and Testing
10.1.1.1. Market Revenue and Forecast
10.1.2. Risk & Compliance Management
10.1.2.1. Market Revenue and Forecast
10.1.3. Model Monitoring and Performance Management
10.1.3.1. Market Revenue and Forecast
10.1.4. Data Governance and Lifecycle Management
10.1.4.1. Market Revenue and Forecast
11.1. Clinical AI Model Governance Market, by End User
11.1.1. Hospitals and Health Systems
11.1.1.1. Market Revenue and Forecast
11.1.2. Pharmaceutical and Biotechnology Companies
11.1.2.1. Market Revenue and Forecast
11.1.3. Clinical Research Organizations (CROs)
11.1.3.1. Market Revenue and Forecast
11.1.4. Health Insurance Providers
11.1.4.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Component
12.1.2. Market Revenue and Forecast, by Deployment Mode
12.1.3. Market Revenue and Forecast, by Application
12.1.4. Market Revenue and Forecast, by End User
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Component
12.1.5.2. Market Revenue and Forecast, by Deployment Mode
12.1.5.3. Market Revenue and Forecast, by Application
12.1.5.4. Market Revenue and Forecast, by End User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Component
12.1.6.2. Market Revenue and Forecast, by Deployment Mode
12.1.6.3. Market Revenue and Forecast, by Application
12.1.6.4. Market Revenue and Forecast, by End User
12.2. Europe
12.2.1. Market Revenue and Forecast, by Component
12.2.2. Market Revenue and Forecast, by Deployment Mode
12.2.3. Market Revenue and Forecast, by Application
12.2.4. Market Revenue and Forecast, by End User
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Component
12.2.5.2. Market Revenue and Forecast, by Deployment Mode
12.2.5.3. Market Revenue and Forecast, by Application
12.2.5.4. Market Revenue and Forecast, by End User
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Component
12.2.6.2. Market Revenue and Forecast, by Deployment Mode
12.2.6.3. Market Revenue and Forecast, by Application
12.2.6.4. Market Revenue and Forecast, by End User
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Component
12.2.7.2. Market Revenue and Forecast, by Deployment Mode
12.2.7.3. Market Revenue and Forecast, by Application
12.2.7.4. Market Revenue and Forecast, by End User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Component
12.2.8.2. Market Revenue and Forecast, by Deployment Mode
12.2.8.3. Market Revenue and Forecast, by Application
12.2.8.4. Market Revenue and Forecast, by End User
12.3. APAC
12.3.1. Market Revenue and Forecast, by Component
12.3.2. Market Revenue and Forecast, by Deployment Mode
12.3.3. Market Revenue and Forecast, by Application
12.3.4. Market Revenue and Forecast, by End User
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Component
12.3.5.2. Market Revenue and Forecast, by Deployment Mode
12.3.5.3. Market Revenue and Forecast, by Application
12.3.5.4. Market Revenue and Forecast, by End User
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Component
12.3.6.2. Market Revenue and Forecast, by Deployment Mode
12.3.6.3. Market Revenue and Forecast, by Application
12.3.6.4. Market Revenue and Forecast, by End User
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Component
12.3.7.2. Market Revenue and Forecast, by Deployment Mode
12.3.7.3. Market Revenue and Forecast, by Application
12.3.7.4. Market Revenue and Forecast, by End User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Component
12.3.8.2. Market Revenue and Forecast, by Deployment Mode
12.3.8.3. Market Revenue and Forecast, by Application
12.3.8.4. Market Revenue and Forecast, by End User
12.4. MEA
12.4.1. Market Revenue and Forecast, by Component
12.4.2. Market Revenue and Forecast, by Deployment Mode
12.4.3. Market Revenue and Forecast, by Application
12.4.4. Market Revenue and Forecast, by End User
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Component
12.4.5.2. Market Revenue and Forecast, by Deployment Mode
12.4.5.3. Market Revenue and Forecast, by Application
12.4.5.4. Market Revenue and Forecast, by End User
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Component
12.4.6.2. Market Revenue and Forecast, by Deployment Mode
12.4.6.3. Market Revenue and Forecast, by Application
12.4.6.4. Market Revenue and Forecast, by End User
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Component
12.4.7.2. Market Revenue and Forecast, by Deployment Mode
12.4.7.3. Market Revenue and Forecast, by Application
12.4.7.4. Market Revenue and Forecast, by End User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Component
12.4.8.2. Market Revenue and Forecast, by Deployment Mode
12.4.8.3. Market Revenue and Forecast, by Application
12.4.8.4. Market Revenue and Forecast, by End User
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Component
12.5.2. Market Revenue and Forecast, by Deployment Mode
12.5.3. Market Revenue and Forecast, by Application
12.5.4. Market Revenue and Forecast, by End User
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Component
12.5.5.2. Market Revenue and Forecast, by Deployment Mode
12.5.5.3. Market Revenue and Forecast, by Application
12.5.5.4. Market Revenue and Forecast, by End User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Component
12.5.6.2. Market Revenue and Forecast, by Deployment Mode
12.5.6.3. Market Revenue and Forecast, by Application
12.5.6.4. Market Revenue and Forecast, by End User
13.1. IBM
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Microsoft
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Google
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. SAS Institute
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. DataRobot
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. H2O.ai
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. NVIDIA
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Oracle
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Fiddler AI
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Arthur AI
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
